Texas 2025 - 89th Regular

Texas House Bill HB2677 Latest Draft

Bill / Introduced Version Filed 02/11/2025

Download
.pdf .doc .html
                            89R5303 AB-D
 By: Thompson H.B. No. 2677




 A BILL TO BE ENTITLED
 AN ACT
 relating to Medicaid coverage and reimbursement for the treatment
 of obesity and certain diabetes prevention program services.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Subchapter B, Chapter 32, Human Resources Code,
 is amended by adding Sections 32.02461 and 32.02462 to read as
 follows:
 Sec. 32.02461.  REIMBURSEMENT FOR TREATING OBESITY.  (a)  In
 this section:
 (1)  "Anti-obesity medication" means a prescription
 medication approved by the United States Food and Drug
 Administration that is indicated for chronic weight management in
 an individual who is diagnosed with obesity.
 (2)  "Intensive health behavioral and lifestyle
 treatment" means an evidence-based, multi-component behavioral or
 lifestyle modification intervention that supports healthy weight
 management.
 (3)  "Metabolic and bariatric surgery" means a surgical
 procedure that:
 (A)  alters the stomach, the intestines, or both
 to cause weight loss in an individual diagnosed with obesity or an
 obesity-related metabolic disorder; and
 (B)  is endorsed by the American Society for
 Metabolic and Bariatric Surgery.
 (4)  "Recipient" means a recipient of medical
 assistance.
 (5)  "Telehealth service" and "telemedicine medical
 service" have the meanings assigned by Section 111.001, Occupations
 Code.
 (b)  The commission shall ensure that medical assistance
 reimbursement is provided for health care services provided to a
 recipient for the treatment of the chronic disease of obesity,
 including:
 (1)  intensive health behavioral and lifestyle
 treatment services;
 (2)  metabolic and bariatric surgery; and
 (3)  anti-obesity medication.
 (c)  Intensive health behavior and lifestyle treatment
 services provided under the medical assistance program may include
 interventions certified or recognized by the Centers for Disease
 Control and Prevention or recommended by current clinical standards
 of care.  The services may be provided in person, including in
 office or in a community-based setting, or remotely as a telehealth
 service or telemedicine medical service.
 (d)  The executive commissioner by rule shall establish
 medical necessity criteria for anti-obesity medications provided
 under the medical assistance program. The criteria may not be more
 restrictive than the indications for the medications that are
 approved by the United States Food and Drug Administration.
 (e)  The commission or a Medicaid managed care organization
 may apply utilization management to determine medical necessity for
 a health care service authorized under this section only if the
 determinations of appropriateness and medical necessity are made in
 the same manner as those determinations are made for other health
 care services provided under the medical assistance program.
 (f)  The executive commissioner shall adopt rules necessary
 to implement this section.
 Sec. 32.02462.  REIMBURSEMENT FOR DIABETES PREVENTION
 PROGRAM SERVICES. (a)  In this section:
 (1)  "Diabetes prevention program" means a program
 designed to prevent or delay the onset of Type 2 diabetes by
 providing a person enrolled in the program a series of structured
 behavioral health change sessions based on a curriculum approved by
 the Centers for Disease Control and Prevention.
 (2)  "Diabetes prevention program supplier" means an
 entity included in the National Registry of Recognized Diabetes
 Prevention Programs maintained by the Centers for Disease Control
 and Prevention.
 (3)  "Recipient" means a recipient of medical
 assistance.
 (b)  The commission shall ensure that medical assistance
 reimbursement is provided to a diabetes prevention program supplier
 for services provided to a recipient enrolled in a diabetes
 prevention program if the recipient:
 (1)  meets the program's eligibility requirements; and
 (2)  has not previously participated in the program
 while a recipient.
 SECTION 2.  If before implementing any provision of this Act
 a state agency determines that a waiver or authorization from a
 federal agency is necessary for implementation of that provision,
 the agency affected by the provision shall request the waiver or
 authorization and may delay implementing that provision until the
 waiver or authorization is granted.
 SECTION 3.  As soon as practicable after the date Section
 32.02461, Human Resources Code, as added by this Act, is
 implemented, the Health and Human Services Commission shall provide
 written notice to recipients of medical assistance under Chapter
 32, Human Resources Code, regarding the availability of obesity
 treatment options under the medical assistance program.
 SECTION 4.  This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution.  If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2025.